Summary
The LucidWave Project introduces a low-cost, very capable, handheld ultrasound probe for medical imaging based on an entirely new ultrasound technology. It aims to provide a light, but powerful imaging tool to a wide range medical professionals for bed-side, point-of-care, office and operating room diagnostics. Doing so it will bring the well-known capabilities of classic ultrasound imaging closer and faster to the patient, helping not only radiologists to make better decisions, but also GP?s, nurses, veterinarians. Consequently, much time, costs and misdiagnosis will be saved for patient and physician.
The project has to following objectives: (I) Starting at TRL 4, develop and deliver 2 full functional prototypes with all parts integrated into one slim device. The capabilities will largely surpass those of current handheld devices. (II) Validate the prototype?s performance in a clinical evaluation. Together with the foundations of a Quality Management System (ISO 13485), it will provide a head start for a later formal Clinical Validation according to the new Medical Device Regulation. (III) Build an entrepreneurial and complementary team by inviting entrepreneurs-in-residence. (IV) In preparation of a start-up a complete and quantified business plan will be created, building on a solid Value Proposition Canvas (incl. user-centric design) which is developed into a Business Model Canvas.
LucidWave fits well into the EIC Transition Programme since it aims to develop a mature proof-of-concept (validated against state-of art) into a prototype ready for Clinical Validation and for scaling-up of the manufacturing. The technical part is complemented with a business strategy for a new and healthy start-up. It addresses one of the key challenges and priorities of Europe, i.e. to build a healthy society.
The project has to following objectives: (I) Starting at TRL 4, develop and deliver 2 full functional prototypes with all parts integrated into one slim device. The capabilities will largely surpass those of current handheld devices. (II) Validate the prototype?s performance in a clinical evaluation. Together with the foundations of a Quality Management System (ISO 13485), it will provide a head start for a later formal Clinical Validation according to the new Medical Device Regulation. (III) Build an entrepreneurial and complementary team by inviting entrepreneurs-in-residence. (IV) In preparation of a start-up a complete and quantified business plan will be created, building on a solid Value Proposition Canvas (incl. user-centric design) which is developed into a Business Model Canvas.
LucidWave fits well into the EIC Transition Programme since it aims to develop a mature proof-of-concept (validated against state-of art) into a prototype ready for Clinical Validation and for scaling-up of the manufacturing. The technical part is complemented with a business strategy for a new and healthy start-up. It addresses one of the key challenges and priorities of Europe, i.e. to build a healthy society.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/101057902 |
| Start date: | 01-07-2022 |
| End date: | 30-06-2025 |
| Total budget - Public funding: | 2 427 025,00 Euro - 2 427 025,00 Euro |
Cordis data
Original description
The LucidWave Project introduces a low-cost, very capable, handheld ultrasound probe for medical imaging based on an entirely new ultrasound technology. It aims to provide a light, but powerful imaging tool to a wide range medical professionals for bed-side, point-of-care, office and operating room diagnostics. Doing so it will bring the well-known capabilities of classic ultrasound imaging closer and faster to the patient, helping not only radiologists to make better decisions, but also GP?s, nurses, veterinarians. Consequently, much time, costs and misdiagnosis will be saved for patient and physician.The project has to following objectives: (I) Starting at TRL 4, develop and deliver 2 full functional prototypes with all parts integrated into one slim device. The capabilities will largely surpass those of current handheld devices. (II) Validate the prototype?s performance in a clinical evaluation. Together with the foundations of a Quality Management System (ISO 13485), it will provide a head start for a later formal Clinical Validation according to the new Medical Device Regulation. (III) Build an entrepreneurial and complementary team by inviting entrepreneurs-in-residence. (IV) In preparation of a start-up a complete and quantified business plan will be created, building on a solid Value Proposition Canvas (incl. user-centric design) which is developed into a Business Model Canvas.
LucidWave fits well into the EIC Transition Programme since it aims to develop a mature proof-of-concept (validated against state-of art) into a prototype ready for Clinical Validation and for scaling-up of the manufacturing. The technical part is complemented with a business strategy for a new and healthy start-up. It addresses one of the key challenges and priorities of Europe, i.e. to build a healthy society.
Status
SIGNEDCall topic
HORIZON-EIC-2021-TRANSITIONCHALLENGES-01-01Update Date
09-02-2023
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
